Identifying risk factor for development of perioperative venous thromboembolism in patients with gastrointestinal malignancy.


Journal

American journal of surgery
ISSN: 1879-1883
Titre abrégé: Am J Surg
Pays: United States
ID NLM: 0370473

Informations de publication

Date de publication:
08 2019
Historique:
received: 02 05 2018
revised: 05 02 2019
accepted: 05 02 2019
pubmed: 24 2 2019
medline: 23 1 2020
entrez: 24 2 2019
Statut: ppublish

Résumé

Current data suggests that decreasing VTE incidence may require focus on other factors. This study aimed to identify perioperative risk factors for VTE in patients undergoing surgery for gastrointestinal (GI) malignancy. Patients undergoing surgery for GI malignancy from 2013 to 2016 were grouped according to whether or not they developed a postoperative VTE, and groups were compared along demographic, perioperative, and outcome variables. Patients who developed VTE were more likely to be older (67 ± 11 VTE vs. 61 ± 10 no VTE, p = 0.04), male (92% vs. 59%, p = 0.02), and have a history of atrial fibrillation (39% vs. 11%, p = 0.01). They also experienced higher intraoperative blood loss (328 ± 724 mL no VTE vs. 918 ± 1885 mL VTE, p = 0.01). On multivariable analysis, history of atrial fibrillation was independently associated with development of postoperative VTE (odds ratio = 3.83, 95% confidence interval = 1.13-13.05, p = 0.03). A prior history of atrial fibrillation independently predicts increased risk of developing VTE after surgery for GI malignancy. Improving understanding of the underlying VTE pathophysiology in these patients can help guide effective prevention strategies.

Sections du résumé

BACKGROUND
Current data suggests that decreasing VTE incidence may require focus on other factors. This study aimed to identify perioperative risk factors for VTE in patients undergoing surgery for gastrointestinal (GI) malignancy.
METHODS
Patients undergoing surgery for GI malignancy from 2013 to 2016 were grouped according to whether or not they developed a postoperative VTE, and groups were compared along demographic, perioperative, and outcome variables.
RESULTS
Patients who developed VTE were more likely to be older (67 ± 11 VTE vs. 61 ± 10 no VTE, p = 0.04), male (92% vs. 59%, p = 0.02), and have a history of atrial fibrillation (39% vs. 11%, p = 0.01). They also experienced higher intraoperative blood loss (328 ± 724 mL no VTE vs. 918 ± 1885 mL VTE, p = 0.01). On multivariable analysis, history of atrial fibrillation was independently associated with development of postoperative VTE (odds ratio = 3.83, 95% confidence interval = 1.13-13.05, p = 0.03).
CONCLUSION
A prior history of atrial fibrillation independently predicts increased risk of developing VTE after surgery for GI malignancy. Improving understanding of the underlying VTE pathophysiology in these patients can help guide effective prevention strategies.

Identifiants

pubmed: 30795857
pii: S0002-9610(18)30628-7
doi: 10.1016/j.amjsurg.2019.02.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

311-314

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Neal Bhutiani (N)

University of Louisville Department of Surgery, Louisville, KY, USA.

Seth A Quinn (SA)

University of Louisville Department of Surgery, Louisville, KY, USA.

Megan K Mercer (MK)

University of Louisville Department of Surgery, Louisville, KY, USA.

Young K Hong (YK)

University of Louisville Department of Surgery, Louisville, KY, USA.

Megan Stevenson (M)

University of Louisville Department of Surgery, Louisville, KY, USA.

Michael E Egger (ME)

University of Louisville Department of Surgery, Louisville, KY, USA.

Prejesh Philips (P)

University of Louisville Department of Surgery, Louisville, KY, USA.

Kelly M McMasters (KM)

University of Louisville Department of Surgery, Louisville, KY, USA.

Robert C G Martin (RCG)

University of Louisville Department of Surgery, Louisville, KY, USA.

Charles R Scoggins (CR)

University of Louisville Department of Surgery, Louisville, KY, USA. Electronic address: charles.scoggins@louisville.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH